APA (7th ed.) Citation

Leboulleux, S., Bastholt, L., Krause, T., de la Fouchardiere, C., Tennvall, J., Awada, A., . . . Schlumberger, M. J. (2012). Vandetanib in locally advanced or metastatic differentiated thyroid cancer: A randomised, double-blind, phase 2 trial. Lancet Oncology, 13(9), 897. https://doi.org/10.1016/S1470-2045(12)70335-2

Chicago Style (17th ed.) Citation

Leboulleux, Sophie, et al. "Vandetanib in Locally Advanced or Metastatic Differentiated Thyroid Cancer: A Randomised, Double-blind, Phase 2 Trial." Lancet Oncology 13, no. 9 (2012): 897. https://doi.org/10.1016/S1470-2045(12)70335-2.

MLA (9th ed.) Citation

Leboulleux, Sophie, et al. "Vandetanib in Locally Advanced or Metastatic Differentiated Thyroid Cancer: A Randomised, Double-blind, Phase 2 Trial." Lancet Oncology, vol. 13, no. 9, 2012, p. 897, https://doi.org/10.1016/S1470-2045(12)70335-2.